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observed relation between viral and allogeneic immunity.
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Introduction: Chronic renal failure (CRF) patients present inability
of the kidney to maintain normal product of protein metabolism,
blood pressure and hematocrit, and also the control of sodium,
water, potassium and acid-base balance. Cellular and humoral im-
mune response and can be depressed so the existence of disorders in
oral health may represent foccus of infection. According the liter-
ature patients under hemodialysis have a 40-50-fold increased risk
of mortality from sepsis compared with the general population. The
monitoring of opportunistic viruses is an extreme importance, since
they are related to comorbidities in these individuals. The objective
of this study was to analyze the presence of human herpesviruses
(HSV1, HSV2, VZV, EBV, CMV, HHV6, HHV7 and HHV8) in saliva
of CRF patients.
Methods: 105 individuals divided into 3 groups according to the
stage of renal disease. Group 1 (n¼13) control group; Group 2
(n¼53) patients with chronic renal disease and group 3 (n¼33) end-
stage renal disease (ESRD) patients in hemodialysis. For saliva
collection was used the technique of salivary ﬂow non-stimulated.
Samples were evaluated by multiplex PCR for herpesviruses.
Results: The herpesviruses CMV, HSV-2, and HHV-8 were not
found in any of the saliva samples. The distribution of herpesvi-
ruses in the study patients is shown in Table 1. The comparison of
the prevalence of HSV-1 between group 3 and 2 showed signiﬁcant
difference (p ¼ 0.0307). EBV, VZV, HHV-6 and HHV-7 did not
show any difference.
Table 1. Distribution of herpesviruses in the 3 groups (number of
patients and percentage)
GROUP N NEGATIVE HSV-1 EBV VZV HHV-6 HHV-7S101 13 3 (23.07 1 (7.69) 7 (53.84) 0 1 (7.69) 7 (53.84)2 53 18 (33.96) 4 (7.54) 25 (47.16) 3 (5.66) 4 (7.54 26 (49.05)3 33 9 (27.27) 8 (24.24) 18 (54.54) 4 (12.12) 1 (3.03) 17 (51.51)The most prevalent co-infection was EBV/HHV-7 detected in
40% of all patients. The distribution of the co-infection of the 3
groups are shown in Table 2. The statistical analysis did not show
difference between the groups, but we detected the association of
the HSV-1/EBV/HHV-7 just in the group 3.
Table 2 - Herpesviruses co-infection in saliva samples (number of
patients and percentage).
HSV-1/ EBV/ HHV- EBV/HHV-6/ EBV/VZV/HHV- HSV-1/EBV/HHV-
GROUP N EBV 7 HHV-7 7 71 10 1 (10.00) 3 (30.00) 1 (10.00) 0 02 35 1 (2.85) 15 (42.85) 15 (42.85) 2 (5.71) 03 24 2 (8.33) 5 (20.83) 5 (20.83) 2 (8.33) 5 (20.83)Conclusions: With the results obtained we can conclude that
serological screening for herpesvirus in chronic renal failurepatients and hemodialysis , which are transplant candidates is
essential to determine its been immune. The prevalence of co-
infection in hemodialysis patients as HSV -1 / EBV / HHV -7 can
cause complications in these patients.
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Introduction: Primary hyperoxaluria is a condition characterized by
overproduction of oxalate. When available in excess, oxalate
combines with calcium to form crystals of calcium oxalate leading
to kidney stone disease. NLRP3 inﬂammasome-mediated renal
inﬂammation was identiﬁed as a prime pathomechanism of acute
oxalate nephropathy (Mulay et. al., JCI 2013) as well as kidney
stone disease (Knauf et. al., KI 2013). In addition, a recent report
demonstrated that -hydroxybutyrate (BHB) inhibited NLRP3-
mediated inﬂammation (Youm YH et. al., Nat Med 2015). Therefore,
we speculated that BHB would ameliorate calcium oxalate (CaOx)
crystals-induced NLRP3-mediated inﬂammation in acute oxalate
nephropathy as well as primary hyperoxaluria related kidney stone
disease.
Methods: C57BL/6 mice at the age of 6-to 8-week old were pur-
chased from Charles River, which received a single intraperitoneal
injection of 100 mg/kg sodium oxalate for the acute calcium oxalate
nephropathy model and kidneys were harvested after 24 hours. For
the chronic model, mice were fed with a low calcium plus Na-
Oxalate diet. In both models, mice were fed with a ketogenic diet
(KD) containing 1,3 butanodiol ketone diesters for 5-7 days before
induce kidney damage. Urine and blood samples were collected at
different time intervals (before and at 3, 7 and 14 days after damage)
and kidneys were used for RNA isolation and histological analysis
(IHC). The kidney function was quantiﬁed by the glomerular
ﬁltration rate (GFR), plasma creatinine and BUN levels at indicated
times. Markers of kidney damage (Kim-1), inﬂammation (IL-6,
MCP-1, RANTES, TNF-) and ﬁbrotic markers (SMA, Col1A1, FSP-1,
Fib-1) were analyzed by RT-PCR and IHC. The BHB levels were
assayed in serum samples with a colorimetric assay kit (Cayman
Chemicals. MI, USA).
Results: We observed that BHB inhibited CaOx crystals-induced
NLRP3-mediated IL-1ß release from bone marrow derived dendritic
cells in a dose dependent manner in vitro. Moreover, feeding of
ketogenic diet (KD) to C57Bl6 mice elevated their plasma BHB levels
and protected them from acute oxalate nephropathy as seen by
decreased plasma BUN and creatinine levels despite similar renal
crystal deposition. KD also reduced tubular injury (PAS, Kim-1),
renal neutrophil inﬁltration and renal inﬂammation (IL-6, TNF,
RANTES and CXCL2) during acute oxalate nephropathy. Similarly,
KD did not change the renal CaOx crystal deposition and plug
formation during kidney stone disease, however still protected mice
from progressive renal failure as seen by improvement in glomer-
ular ﬁltration rate (GFR) and decreased plasma BUN and creatinine
levels. Elevated plasma BHB levels after KD administrationKidney International Reports (2016) 1, S1–S22
TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016correlated with the reduction of tubular injury (PAS, Kim-1), renal
inﬂammation (Macrophages, T cells, IL-6, TNF-, RANTES and
CCL2) as well as renal ﬁbrosis (SMA, Col1a1, Masson Trichrome).
Conclusions: Therefore, we conclude that BHB ameliorates acute
oxalate nephropathy, as well as delays progressive renal failure by
inhibiting NLRP3-mediated inﬂammation. Our ﬁndings suggest
that ketogenic diets or -hydroxybutyrate formulations can be used
therapeutically for the treatment of primary hyperoxaluria related
kidney stone disease.
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Introduction: A newly-described 1st-line immune defence mecha-
nisms of neutrophils is the extrusion of DNA, called neutrophil
extracellular traps (NETs). Known non-infectious triggers of
NETosis are phorbol 12-myristate 13-acetate (PMA), IL-8 and im-
mune complexes (ICx). In vitro, PMA and IL-8 are strong inducers
of NET release and generally involves all cultured neutrophils.
However, ICx induce much lower numbers of neutrophils to release
NETs. As such, the in vitro quantiﬁcation of NETs is challenging
with current methodologies (i.e. Picogreen or immunoﬂuorescence).
In order to investigate the role of NET release in ICx-mediated
autoimmune diseases, we developed a novel method for automated
and highly sensitive measurement of NETs, applicable in a
high-throughput system.
Methods: Healthy neutrophils are isolated from fresh blood and
labelled with the membrane staining PKH26, which serves as a cell
marker. Neutrophils are stimulated for 4 hours with various con-
centrations of heat-aggregated human IgG ICx. After 33/4 hours,
Sytox green is added to stain extracellular DNA. Sytox green is
incubated for 15 minutes, after which the cells are ﬁxed with 4%
PFA. Within 24 hours, the 96-well plate is automatically imaged
with the BD Pathway 855. The ratio of the sum of Sytox green area
and average PKH area is calculated, representing the amount of
NETs in each sample. A higher ratio indicates a higher amount of
extracellular DNA present.
Results: Immunoﬂuorescence analysis of ICx-stimulated neutro-
phils revealed colocalization of extracellular DNA staining with
citrullinated histon3 and neutrophil elastase, conﬁrming the release
of NETs. The amount of NET release was quantiﬁed with ImageJ
software, by determining the ratio between positive Sytox green
area and the positive PKH26 area, of which we found that it
accurately represents the amount of cells imaged. Sensitivity is
highly increased since 11% of the total area per well is imaged and
a z-stacking system is used to image NETs superimposed on neu-
trophils. We further characterized NET release upon stimulation
with these ICx. When pre-treated with diphenyleneiodonium (DPI),
used to block production of reactive oxygen species (ROS), NET
release upon ICx stimulation was not affected.Kidney International Reports (2016) 1, S1–S22Conclusions:We developed a novel assay that is highly sensitive to
detect and quantify in vitro NET release. NET release triggered by
human ICx was detected reliably and appeared to be a ROS-inde-
pendent process. This assay will allow high-throughput and highly
sensitive analysis of NET release in ICx-mediated autoimmune
diseases (e.g. systemic lupus erythematosus, rheumafactor positive
rheumatoid arthritis or cryoglobulinemic vasculitis).
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Introduction: IL-33 is an important immune regulator which can
promote Th2 immune response-dependent immunity, inﬂammation,
and tissue repair in several important immune-mediated disorders.
In the current study, we sought to determine whether IL-33 is an
important regulator in renal ischaemic/reperfusion injury (IRI).
Methods: Bilateral renal ischemia was imposed in C57BL/6 mice
under isoﬂuorane anesthesia. IL-33 was given by 5 consecutive
daily injections starting at day 5 before IRI operation. Adoptive
transfer of type 2 innate lymphoid cells into mice with IRI was used
to assess their in vivo functions.
Results: Treating IRI mice with IL-33 signiﬁcantly improved renal
function and reduced renal injury. The possible mechanisms un-
derlying the protective effect of IL-33 were examined. Firstly, IL-33
increased the levels of IL-4, IL-5 and IL-13 in serum and kidney and
promoted induction of alternatively activated (M2) macrophages in
kidney. Moreover, the number of NK cells and neutrophils was
signiﬁcantly reduced in IRI mice treated with IL-33. A novel
ﬁnding of this study was that IL-33 increased the frequency of type
2 innate lymphoid cells (ILC2) and regulatory T cells (Tregs) in
kidney. However, adoptive transfer of ILC2 not only reduced renal
functional and histological injury in IRI mice but also induced M2
macrophages in kidney.
Conclusions: In conclusion, our data identify a mechanism
whereby IL-33 eliciting ILC2 and Tregs regulate macrophage
phenotype in kidney and prevent renal IRI.
P24
RORÎ3t+ FOXP3+ BITREGS PROMOTE
LUPUS NEPHRITIS VIA IL-17
SECRETION AND SUPPRESSION OF
TH2 RESPONSES
Kluger, M1, Nosko, A1, Goerke, B1, Luig, M1, Stahl, RAK1,
Steinmetz, OM1
1Universitaetsklinikum Hamburg-Eppendorf, III.Medizinische Klinik, Hamburg,
Germany
Introduction:We have recently characterized Foxp3+ regulatory T
cells, co-expressing the Th17 characteristic transcription factor
ROR t, as an independent and bi-functional T cell lineage (biTregs).
biTregs secrete both, anti-inﬂammatory (IL-10, IL-35), but also pro-
inﬂammatory (IL-17) cytokines. Studies in a model of acute cres-
centic glomerulonephritis have suggested that pro- inﬂammatory
biTreg functions are largely mediated by ROR t. This is of high
clinical relevance, since multiple ROR t blocking agents areS11
